Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
MALDI-TOF Mass Spectrometry01:19

MALDI-TOF Mass Spectrometry

Mass spectrometry is a powerful characterization technique that can identify and separate a wide variety of compounds ranging from chemical to biological entities, based on their mass-to-charge ratio (m/z). The instruments that allow this detection, known as mass spectrometers, have three components: an ion source, a mass analyzer, and a detector. These spectrometers differ based on the nature of their ion source and analyzers.Matrix-assisted laser desorption ionization (MALDI) is a commonly...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Symptom, functional, and medication overlap between long COVID and fibromyalgia.

Clinics (Sao Paulo, Brazil)·2026
Same author

Clustering-based stratification of fibromyalgia subtypes: A comparative analysis of medicated and non-medicated cohorts from two academic centers.

Seminars in arthritis and rheumatism·2026
Same author

Depression, pain, and functional impairment across fibromyalgia, rheumatoid arthritis, and systemic lupus erythematosus: A cross-condition analysis and mediation model.

Journal of psychosomatic research·2026
Same author

Metabolic outcomes of bictegravir/emtricitabine/tenofovir alafenamide versus dolutegravir/lamivudine in treatment-naïve people living with HIV: a 48-week retrospective study.

Expert review of anti-infective therapy·2026
Same author

Serum Extracellular Vesicle Protein Signatures Associated with Early-Stage High-Grade Serous Ovarian Carcinoma.

Cells·2026
Same author

Berry-derived gold nanoparticles induce integrated ROS-mediated apoptosis, immune modulation, and transcriptomic remodeling in 4T1 triple-negative cancer cells.

Cell death discovery·2026

Related Experiment Video

Updated: Jun 23, 2026

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers
08:33

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers

Published on: January 5, 2024

Point-of-care Diagnostic Framework for Fibromyalgia Using Integrated Vibrational Spectroscopy and Metabolomics.

Shreya Madhav Nuguri1,2, Luis Rodriguez-Saona2, Chengyu Gao3

  • 1Department of Internal Medicine, Dell Medical School, The University of Texas, 1601 Trinity St, Austin, TX 78712, USA.

Research Square
|June 22, 2026
PubMed
Summary
This summary is machine-generated.

This study shows a new method combining spectroscopy and metabolomics can help objectively diagnose fibromyalgia (FM) by identifying specific biomarkers in blood, differentiating it from rheumatoid arthritis (RA) and healthy controls.

Keywords:
FibromyalgiaMetabolomicsPoint-of-care diagnosisTranslationalVibrational spectroscopy

More Related Videos

FIBS-enabled Noninvasive Metabolic Profiling
09:16

FIBS-enabled Noninvasive Metabolic Profiling

Published on: February 3, 2014

An Integrated Workflow of Identification and Quantification on FDR Control-Based Untargeted Metabolome
05:35

An Integrated Workflow of Identification and Quantification on FDR Control-Based Untargeted Metabolome

Published on: September 20, 2022

Related Experiment Videos

Last Updated: Jun 23, 2026

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers
08:33

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers

Published on: January 5, 2024

FIBS-enabled Noninvasive Metabolic Profiling
09:16

FIBS-enabled Noninvasive Metabolic Profiling

Published on: February 3, 2014

An Integrated Workflow of Identification and Quantification on FDR Control-Based Untargeted Metabolome
05:35

An Integrated Workflow of Identification and Quantification on FDR Control-Based Untargeted Metabolome

Published on: September 20, 2022

Area of Science:

  • Biomarker Discovery
  • Metabolomics
  • Spectroscopy
  • Rheumatic Diseases

Background:

  • Objective diagnostic tools are needed for syndromes like fibromyalgia (FM), which are currently diagnosed via subjective questionnaires.
  • FM diagnosis is challenging due to symptom overlap with conditions such as rheumatoid arthritis (RA).
  • This study explores a combined spectroscopic-metabolomic workflow for objective FM diagnosis.

Purpose of the Study:

  • To evaluate the feasibility of a combined Fourier-transform infrared (FTIR) spectroscopy and mass spectrometry (MS)-based metabolomic workflow.
  • To distinguish between fibromyalgia (FM), rheumatoid arthritis (RA), and healthy controls (HC) using blood samples.
  • To identify potential biomarkers and metabolic pathways associated with fibromyalgia.

Main Methods:

  • Analyzed whole blood from 40 FM patients, 20 RA patients, and 10 HC participants.
  • Employed portable FTIR spectroscopic fingerprinting and MS-based metabolite identification.
  • Utilized Soft Independent Modeling by Class Analogy (SIMCA) and Partial Least Squares Discriminant Analysis (PLS-DA) for classification, and Partial Least Squares Regression (PLSR) for correlating spectral data with metabolites.

Main Results:

  • Achieved good classification between FM and HC groups using SIMCA models (interclass distances > 4.1).
  • Identified oligopeptides, inosine monophosphate, and signaling lipids as key differentiators, suggesting dysregulation in oxidative stress, inflammation, and metabolic pathways.
  • Demonstrated strong correlations between FTIR spectral features and identified metabolites like inosine monophosphate and N-acylethanolamines (NAE).

Conclusions:

  • The integrated FTIR spectroscopic and MS-driven metabolomic approach shows potential for identifying objective fibromyalgia (FM) signatures.
  • The workflow achieved strong classification performance and metabolite correlations.
  • This approach could be translated into a rapid, point-of-care diagnostic tool for FM.